Early Findings of Computed Tomography and Angiography in Acute Stroke and Thrombolytic Therapy
Before thrombolytic treatment in acute stroke, a computed tomographic (CT) scan is necessary to exclude brain hemorrhage and other causes of focal neurological deficit imitating cerebral ischemia. Angiographic demonstration of arterial occlusion is a precondition for local intraarterial infusion of thrombolytics. At present, several major clinical trials testing the effect of intravenous thrombolytic treatment in acute stroke are conducted without the information of initial angiography so as to gain time for early treatment [1–3]. So far, there are only a few reports available concerning the significance of CT scan and angiography for thrombolytic treatment [4–7]. We studied the question whether positive signs of cerebral ischemia in CT scan such as parenchymal hypodensity and focal brain swelling, together with the angiographically proved site of arterial occlusion and state of collateral blood supply, have predictive value for arterial recanalization and clinical outcome in hemispheric stroke. The significance of angiography in basilar artery occlusion is reported elsewhere in these proceedings (See Chapter, “Thrombolytic Therapy of Basilar Artery Occlusion: Preconditions for Recanalization and Good Clinical Outcome,” in this volume). Data of subgroups of patients reported here have been published previously [8–10].
KeywordsMiddle Cerebral Artery Occlusion Acute Ischemic Stroke Thrombolytic Therapy Arterial Occlusion Thrombolytic Treatment
Unable to display preview. Download preview PDF.
- 4.Wolpert SM, Brückmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ, and the rt-PA Acute Stroke Study Group (1993) Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR 14: 3–13Google Scholar
- 10.von Kummer R, Meyding-Lamadé U, Forsting M, Rosin L, Rieke K, Hacke W, Sartor K (1994) Sensitivity and prognostic value of early computed tomography in middle cerebral artery trunk occlusion. AJNR 15: 9–15Google Scholar
- 13.del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin J, Wechsler L, Busse O, Greenlee R, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32: 78–86PubMedCrossRefGoogle Scholar